Epizyme identifies novel opportunity for treatment of genetically defined human B-cell lymphomas
Research in PNAS reveals unique role of EZH2 enzyme in cancer, facilitating development of selective small molecule therapeutics
2010-11-16
(Press-News.org) Cambridge, MA, November 15, 2010 - Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas. EZH2 is a histone methyltransferase (HMT), a class of enzymes that play an important role in regulating the activity of particular groups of genes that are involved in serious diseases, including cancer.
The paper describes how the development of two non-Hodgkin lymphomas - follicular lymphoma and germinal center B-cell like subtype of diffuse large B-cell lymphoma - requires the combined activities of both the wild-type and Tyr641 mutants of EZH2. This novel insight reinforces the development of targeted therapeutics for these patients, as it repudiates the previous supposition that the Tyr641 mutation resulted in a loss of EZH2 function.
Dr. Robert A. Copeland, EVP of R&D and CSO, said, "We believe this is the first example of a human disease that is reliant on the combined catalytic activity of both normal and disease-associated mutant enzymes. By targeting HMTs with clear genetic disease associations, such as EZH2, Epizyme takes a hypothesis-driven approach to development of personalized therapeutics for specific patient populations with high unmet needs. Our product platform enables the creation of novel, potent and selective small molecule HMT inhibitors."
"This paper is a novel, important and representative example of the rapidly growing understanding of the oncogenic role played by HMTs in many cancers. It highlights the promise of HMT inhibitors as novel therapeutics against these targets," said Professor Christopher T. Walsh, the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology (BCMP) at Harvard Medical School and a member of Epizyme's Scientific Advisory Board.
INFORMATION:
The paper, entitled "Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas" by Christopher J. Sneeringer, Margaret Porter Scott, Kevin W. Kuntz, Sarah K. Knutson, Roy M. Pollock, Victoria M. Richon, and Robert A. Copeland, will appear in the Proceedings of the National Academy of Sciences during the week of November 15.
About Epizyme
Epizyme is leading the discovery and development of small molecule histone methyltransferase (HMT) inhibitors, a new class of targeted therapeutics for the treatment of genetically-defined cancer patients based on breakthroughs in the field of epigenetics. Genetic alterations in the HMTs are strongly associated with the underlying causes of multiple human diseases, including cancer. Epizyme's hypothesis-driven approach represents the future of personalized therapeutics by creating better medicines for the right patients more quickly and at lower cost than traditional approaches. www.epizyme.com
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-16
To mark The World Day of Remembrance for Road Traffic Victims, which takes place on Sunday November 21st, PLoS Medicine publishes two research articles on Road Traffic Crashes.
The World Day of Remembrance for Road Traffic Victims takes place on the third Sunday of November every year as the appropriate acknowledgment of victims of road traffic crashes and their families. It was started by RoadPeace in 1993 and was adopted by the United Nations General Assembly in 2005.
Prescribed medicines are responsible for over 3% of road traffic crashes in France
In France, ...
2010-11-16
Disruptive behaviour disorders in male teenagers, such as attention deficit hyperactivity disorder, conduct disorder, and oppositional defiant disorder are associated with about a one-third increase in the risk of being seriously injured in a road traffic crash – either as driver or pedestrian. This increase is similar to the increased relative risk found for patients treated for epilepsy. These are the findings of a study by Donald Redelmeier and colleagues from the University of Toronto, Toronto, Canada, and published in this week's PLoS Medicine. Male teenagers are ...
2010-11-16
CAMBRIDGE, Mass. -- A sophisticated new examination of teeth from 11 Neanderthal and early human fossils shows that modern humans are slower than our ancestors to reach full maturity. The finding suggests that our characteristically slow development and long childhood are recent and unique to our own species, and may have given early humans an evolutionary advantage over Neanderthals.
The research, led by scientists at Harvard University, the Max Planck Institute for Evolutionary Biology (MPI-EVA), and the European Synchrotron Radiation Facility (ESRF), is detailed in ...
2010-11-16
Specific, relatively uncommon variations at a region of human chromosome 8 have recently been linked to fat (lipid) levels in the blood that decrease an individual's risk of atherosclerosis (a disease of the major arterial blood vessels that is a main cause of heart attack and stroke). The only currently described gene in this region of chromosome 8 is TRIB1, but it has not been previously linked in any way to regulation of lipid levels. Now, a team of researchers, led by Jan Breslow, at The Rockefeller University, New York, and Daniel Rader, at the University of Pennsylvania ...
2010-11-16
EDITOR'S PICK: At-TRIB(1)-uting a gene a new function in the liver
Specific, relatively uncommon variations at a region of human chromosome 8 have recently been linked to fat (lipid) levels in the blood that decrease an individual's risk of atherosclerosis (a disease of the major arterial blood vessels that is a main cause of heart attack and stroke). The only currently described gene in this region of chromosome 8 is TRIB1, but it has not been previously linked in any way to regulation of lipid levels. Now, a team of researchers, led by Jan Breslow, at The Rockefeller ...
2010-11-16
The active involvement of health professionals in hygiene, sanitation, and water supply is absolutely crucial to accelerating and consolidating global health progress, says a new series of papers in PLoS Medicine by a leading group of public health academics and water advocates.
Professor Sandy Cairncross from the London School of Hygiene & Tropical Medicine (LSHTM) and colleagues show how water and sanitation issues are woefully neglected across the world and suggest that action could prevent more than 2 million children dying each year.
The authors say that in 2010, ...
2010-11-16
While automated external defibrillators improve survival for out-of-hospital cardiac arrest, an analysis of data indicates their use for cardiac arrest in a hospital does not result in an improved rate of survival, according to a study in the November 17 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.
Use of automated external defibrillators (AEDs) has been proposed as a strategy to reduce times to defibrillation and improve survival from cardiac arrests that occur in the hospital ...
2010-11-16
Multiple testing with the cardiac diagnostic imaging technique of myocardial perfusion imaging is common, and in many patients is associated with a high cumulative estimated radiation dose, according to a study in the November 17 issue of JAMA. The study is being released early online because it is being presented at the American Heart Association's annual meeting.
Use of medical imaging has grown rapidly in recent years, but along with the potential benefits has come an increase in the amount of ionizing radiation associated with many such tests and the accompanying ...
2010-11-16
Certain measures of the blood biomarker cardiac troponin T (cTnT), a cardiac-specific protein, using a highly sensitive test, are associated with the development of heart failure or cardiovascular death in older adults, according to a study that will appear in the December 8 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.
"Older adults comprise the majority of new-onset heart failure (HF) diagnoses, but traditional risk-factor prediction models have limited accuracy in this population ...
2010-11-16
Surgical items, such as sponges and small instruments, left in the bodies of children who undergo surgery are quite uncommon and rarely fatal but decidedly dangerous and expensive mistakes, according to a Johns Hopkins Children's Center study to be published in the November issue of JAMA-Archives of Surgery.
Such errors added eight days, on average, to a young patient's hospital stay and nearly $36,000 in extra hospital charges, both stemming from complications and the need for follow-up surgery to retrieve the forgotten objects.
Analyzing more than 1.9 million records ...
LAST 30 PRESS RELEASES:
[Press-News.org] Epizyme identifies novel opportunity for treatment of genetically defined human B-cell lymphomas
Research in PNAS reveals unique role of EZH2 enzyme in cancer, facilitating development of selective small molecule therapeutics
